Evidence Hub

Incidence, management, and outcomes of procarbazine-associated hypersensitivity reactions in patients receiving PCV for lower-grade gliomas

Knott JL, Liebling SP, Reed-Guy L, Croteau D, Phillips RE, Desai AS, Bagley SJ

Neuro-oncology practice, 2025

61 participants

Abstract

Background: The use of procarbazine in the treatment of lower-grade gliomas as part of the procarbazine, lomustine, and vincristine (PCV) regimen is frequently limited by the development of hypersensitivity reactions (HSRs), which often require dose reduction or cessation of procarbazine therapy prior to the completion of a planned treatment course. The incidence, clinical characteristics, and potential predictors of these reactions are not well defined.

Methods: We conducted a retrospective cohort study of patients with lower-grade gliomas who received PCV between January 2016 and January 2024 at a tertiary medical center. Data on patient demographics, tumor type, clinical characteristics, treatment course, and HSRs were collected. A total of 61 patients were included.

Results: The overall incidence of procarbazine-associated HSRs was 60.7% (95% CI: 48.4%-72.9%). All HSRs involved the development of rash, with 86.5% being pruritic and 21.6% involving the face. Treatments for HSRs included antihistamines (62.2%), topical corticosteroids (35.1%), and systemic corticosteroids (27.0%). Patients who experienced procarbazine-associated HSRs received significantly fewer cycles of procarbazine compared to those who did not experience HSRs (P < .001). 83.8% of patients with HSRs permanently discontinued procarbazine. Three patients with HSRs presented to the emergency department with concern for anaphylaxis, and one required treatment with epinephrine. One of 6 rechallenged patients…

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 61 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free